2025 Fall Conference | C22 - Revolutionizing ALS Treatment: The Tofersen Breakthrough
| 03:00 PM - 03:45 PM PDT | Speaker |
Tofersen Therapy for ALS
Timothy M. Miller, MD, PhD |
| 03:45 PM - 04:30 PM PDT | Speaker |
Neuromuscular Rehabilitation in Successfully Treated ALS Patients
Sean E. Smith, MD, MPHS |
| Timothy M. Miller, MD, PhD | Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Bio. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Miller has received intellectual property interests from a discovery or technology relating to health care. Dr. Miller has received intellectual property interests from a discovery or technology relating to health care. |
| Sean E. Smith, MD, MPHS | Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inThought. |